EUCTR2005-005040-85-AT进行中（未招募）不适用
Comparison of Albumin 5%, Hydroxyethyl Starch 130/0.4 (6%) and Ringer Lactate for volume replacement during cardiac surgery - n/a
Department of Anesthesia, Div. of Cardiothoracic and Vascular Anesthesia, Medical University Vienna0 个研究点目标入组 240 人开始时间: 2006年2月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Patients undergoing elective cardiac surgery using cardiopulmonary bypass including coronary artery bypass grafting (CABG), valve repair or replacement, and Aorta ascendens surgery
- •2) Age > 18 years
- •3) Written informed consent obtained
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) Known allergy to Hydroxyethyl starch or Albumin
- •2) Aspirin use less than 3 days before surgery
- •3) GPIIbIIIa antagonists use less than 7 days before surgery
- •4) Coagulation disorders (INR > 1.2, aPTT > 40sec, platelet count < 100.000)
- •5) BMI > 40
- •6) Left ventricular ejection fraction < 15%
- •7) Renal dysfunction defined as serum creatinine >1.5mg/dl
- •8) Proven heparin induced thrombocytopenia (Danaparoid, Lepirudin use less than 1 month)
- •9) Deny of consent
研究者
相似试验
进行中（未招募）
不适用
Comparison of 6% Hydroxyethyl Starch and 5% Albumin for Volume Replacement Therapy in Patients Undergoing Elimination of the Bladder (CHART study)Comparison of 6% Hydroxyethyl Starch and 5% Albumin for Volume Replacement Therapy in Patients Undergoing CystectomyMedDRA version: 15.1Level: LLTClassification code 10021139Term: HypovolemiaSystem Organ Class: 100000004861EUCTR2010-018343-34-DEudwigs Maximilians University
已完成
不适用
Comparison of 6% hydroxyethyl starch(130/0.4) with 5% albumin as intraoperative fluid during major abdominal surgerycarcinoma of liver, gallbladder, and pancreasJPRN-UMIN000013417Saitama Medical University50
进行中（未招募）
1 期
Effects of hydroxyethyl starch 130/0.4 compared to a balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis - The 6S TrialSevere sepsis or septic shockMedDRA version: 9.1Level: LLTClassification code 10040070Term: Septic shockMedDRA version: 9.1Level: LLTClassification code 10053879Term: Sepsis syndromeEUCTR2009-010104-28-FIDept. of Intensive Care, Rigshospitalet800
进行中（未招募）
不适用
orræn vísindarannsókn á notkun sterkjulausna í alvarlegri sýklasótt eða sýklasóttarlosti – 6S rannsókniSevere sepsis or septic shockEUCTR2009-010104-28-ISDept. of Intensive Care, Rigshopitalet800
进行中（未招募）
不适用
Effects of hydroxyethyl starch 130/0.4 compared to a balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis - The 6S TrialSevere sepsis or septic shockMedDRA version: 13.1Level: PTClassification code 10040070Term: Septic shockSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 13.1Level: PTClassification code 10053879Term: Sepsis syndromeSystem Organ Class: 10021881 - Infections and infestationsEUCTR2009-010104-28-DKDept. of Intensive Care, Rigshospitalet800